Trial intelligence / Profile preview

Perioperative Dronabinol in Total Knee Arthroplasty

NCT04734080Phase 4Completed

Sponsor
Hospital for Special Surgery
Start
Mar 2021
Primary completion
Oct 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in postoperative pain comparing Dronabinol with Placebo (2 arms). Primary endpoint: Cumulative Opioid Consumption 24-48 Hours Post-operatively. Started Mar 2021; status: completed.

02

Drugs

dronabinol
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT04734080.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04734080.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call